Method for measuring the rate of cell reproduction by analysis of nanoliter cell samples
View Patent ↗A method of detecting cancer using a laser biocavity having a semiconductor laser including a microchannel through which cells in fluid traverse, comprising determining the laser wavelength of the laser biocavity with only fluid in the microchannel; determining the wavelength shift of the biocavity when each cell passes through the microchannel; and determining the percentage of cells in G2 phase from the wavelength shift of the cells; wherein an increased percentage of G2 phase cells is an indication of cancer.
1. A method of determining a rate of cell reproduction using a laser biocavity including a semiconductor laser, comprising:
a) determining a laser wavelength of a laser biocavity;
b) determining a wavelength shift of the laser wavelength of the laser biocavity when a cell in a fluid passes through a microchannel of the laser biocavity;
c) categorizing a phase of the cell by comparing the wavelength shift of the laser wavelength of the laser biocavity to a wavelength shift generated by a G2 phase call of the same type as the cell in the fluid to determine whether the cell is in a G2 phase;
d) determining the phase of a plurality of cells by repeating steps b and c; and
e) determining a percentage of the plurality of cells in a G2 phase as an indication of the rate of cell reproduction.
2. The method of claim 1 wherein the step of determining the percentage of the plurality of cells comprises counting a total number of the cells which have passed through the microchannel and counting a number of the cells which have passed through the microchannel that produce a wavelength shift corresponding to the laser wavelength of the laser biocavity containing a cell in the G2 phase.
3. The method of claim 1 wherein the step of determining the percentage of the plurality of cells in a G2 phase comprises forming a histogram of a number of the cells as a function of the wavelength shift produced by each of the cells, and comparing a number of cells at a wavelength shift corresponding to the laser wavelength of the laser biocavity containing the cells in the G2 phase with a number of cells at a wavelength shift corresponding to the laser wavelength of the laser biocavity containing the cells in the G1 phase.